Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding...

|About: Baxter International Inc (BAX)|By:, SA News Editor

Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding better opportunities in the healthcare sector. Analysts with the firm maintain their Buy rating, while clipping the price target on shares by a $1 to $59. Shares +0.4% premarket.